BCHE and Alzheimer disease: As expected, the MCI-LB group had more Parkinsonism, and higher cognitive fluctuation and visual hallucination scores compared to the MCI-AD group and more MCI-LB participants were taking cholinesterase inhibitors and Parkinson’s medication.